Document is current
Any future updates will be listed below
-
Authors
Campos, Susana https://orcid.org/0000-0001-9672-473X
Matulonis, Ursula
Berlin, Suzanne
Horowitz, Neil
Liu, Joyce
Krasner, Carolyn
Hang, Lee
Zarwan, Corrine
Barry, William
Colella, Tina
Whalen, Christen
Shoni, Melina
Lundquist, Christine
Birrer, Michael J.
Penson, Richard
-
Funding
Funding for this research was provided by:
Genentech
- License Information
-
More Information
Article History
Received: 17 February 2022
Accepted: 21 September 2022
First Online: 8 November 2022
Declarations
:
: Susana Campos: Honoraria (e.g., lecture fees): advisory board: Campos, GSK, Eisai, Novartis. Ursula Matulonis: Employment/Leadership position/advisory role: Novartis, Advisory Board, AstraZeneca, Consulting, NeXT Care, Consulting, Merck, Consulting. Joyce Liu: Others (e.g., trips, travel, or gifts): advisory boards for AstraZeneca, Clovis, Genentech, Merck, Regeneron, and Tesaro/GSK. Richard Penson: Honoraria (e.g., lecture fees): Abbvie, Cancer Panels, Care4ward (Unpaid), Eisai, Genentech, Intellisphere, Merck & Co., Sutro Biopharma, Tesaro Inc., Vascular Biogenics Ltd, WebMD, Research funding: Array Biopharma Inc., AstraZeneca, Eisai Inc., Genentech, Inc., Regeneron, Sanofi-Aventis US LLC, Tesaro Inc., Vascular Biogenics Ltd. Suzanne Berlin, Neil Horowitz, Michael Birrer, Carolyn Krasner, William Barry, Corinne Zarwan, Hang Lee, Tina Colella, Christin Whalen, Melina Shoni, Christine Lundquist declare that they have no conflict of interest.
